AI Article Synopsis
- Idiopathic pulmonary arterial hypertension (IPAH) is a rare condition affecting 500-1000 individuals yearly, with some cases linked to mutations in the BMPR2 gene, indicating a genetic factor in its onset.
- Researchers have developed two human induced pluripotent stem cell (iPSC) lines from IPAH patients, which can serve as models to study the disease.
- These iPSC lines will help researchers gain insights into the biological processes underlying IPAH and could aid in developing new treatments.
Article Abstract
Idiopathic pulmonary arterial hypertension (IPAH) is a rare disease, with an estimated 500-1000 new cases diagnosed every year. A portion of these cases may be caused by mutations in the BMPR2 gene, suggesting a possible genetic component in the development of the disease. Here, we report two human induced pluripotent stem cell (iPSC) lines generated from IPAH patients. Both cell lines provide valuable insight into the molecular and cellular mechanisms of IPAH and can be used to further understand the disease.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11006094 | PMC |
| http://dx.doi.org/10.1016/j.scr.2023.103218 | DOI Listing |
Publication Analysis
Top Keywords
induced pluripotent
8
pluripotent stem
8
stem cell
8
cell lines
8
generation induced
4
lines patients
4
patients suffering
4
suffering pulmonary
4
pulmonary hypertension
4
hypertension idiopathic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!